Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01702012 · ClinicalTrials.gov registry record · NA
Almased Multi-Center Diabetes Intervention Trial
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
NCT01702012 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 240 participants.
The verdict
NCT01702012, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
Study Summary
A 12 month multi-center randomization controlled study. Participants will be randomized to either a lifestyle education program or a meal replacement regimen with Almased, after an initial examination of eligibility criteria. Primary outcome-HbA1c
Interventions
- DIETARY_SUPPLEMENT Almased Meal Replacement Powder
- BEHAVIORAL Group-Based Lifestyle Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01702012
The ClinicalTrials.gov registry entry for NCT01702012 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Almased Meal Replacement Powder is the first listed.
NCT01702012 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01702012 about?
NCT01702012 is a clinical study titled "Almased Multi-Center Diabetes Intervention Trial". A 12 month multi-center randomization controlled study. Participants will be randomized to either a lifestyle education program or a meal replacement regimen with Almased, after an initial examination of eligibility criteria. Primary outcome-HbA1c
What is the current status of trial NCT01702012?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2013-01. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01702012?
The interventions under investigation include: Almased Meal Replacement Powder (DIETARY_SUPPLEMENT), Group-Based Lifestyle Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01702012?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.